OptiBiotix Health Plc (LON:OPTI – Get Free Report)’s share price was down 9.8% on Thursday . The company traded as low as GBX 5.91 and last traded at GBX 5.95. Approximately 1,019,421 shares were traded during mid-day trading, an increase of 187% from the average session volume of 355,105 shares. The stock had previously closed at GBX 6.60.
OptiBiotix Health Trading Down 9.4%
The firm’s 50 day simple moving average is GBX 5.80 and its 200-day simple moving average is GBX 5.74. The stock has a market capitalization of £6.18 million, a price-to-earnings ratio of -1.56 and a beta of 1.82.
OptiBiotix Health (LON:OPTI – Get Free Report) last posted its quarterly earnings data on Thursday, September 17th. The company reported GBX (1.52) EPS for the quarter. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.
About OptiBiotix Health
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
Further Reading
- Five stocks we like better than OptiBiotix Health
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
- Apple Is Quietly Building an AI Advantage Few Expected
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
